-
API Supply: COVID-19 Industry Update
contractpharma
March 09, 2020
A breakdown of manufacturing facilities making active pharmaceutical ingredients (APIs) for U.S. market.
-
Science and Technology Daily: Chorus of a Community of Shared Future for Mankind -- China Unite the World to Fight Against the Covid-19
Science and Technology Daily
March 09, 2020
A timeline clearly recorded how China has taken the initiative to fulfill its international responsibilities and unite with the global society to fight against Covid-19. After the coronavirus outbroke, China immediately informed the WHO of the incident an
-
MSB Viet Nam announces relief measures for COVID-19 affected customers
prnasia
March 06, 2020
Facing the increasingly complicated situation of the COVID-19 outbreak which has caused significant impacts on the global economy and Vietnam's itself, banks and credit institutions have together rolled out measures in a form of pragmatic solutions to pro
-
Orient Commercial Joint Stock Bank supports customers (corporate and retail) for preventing consequences from COVID-19
prnasia
March 06, 2020
Once receiving the Official Letter from State Bank of Vietnam (No. 541 / NHNN-TD) on supporting the recovery of damage caused by the COVID-19 epidemic, Orient Commercial Joint Stock Bank (OCB) has reacted quickly.
-
EpiVax Accelerates COVID-19 Vaccine Development
americanpharmaceuticalreview
March 06, 2020
EpiVax announces a collaboration to develop a novel coronavirus SARS-CoV-2 (COVID-19) vaccine with University of Georgia’s Ted Ross (Director, Center for Vaccines and Immunology (CVI)).
-
China’s Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19
Businesswire
March 06, 2020
The epidemic of COVID-19 remains a prominent healthcare challenge, affecting more than 70 countries and regions over the world. This rapid widespread has made more countries realize the need for international collaboration to address this global concern.
-
Inovio Pharmaceuticals set to trial Covid-19 vaccine in April
pharmaceutical-technology
March 05, 2020
Inovio Pharmaceuticals has expedited its timeline for the development of a Covid-19 vaccine candidate, INO-4800, with human clinical trials scheduled for April.
-
Iktos and SRI to use AI for Covid-19 drug development
pharmaceutical-technology
March 05, 2020
Artificial intelligence (AI) technology provider Iktos and research centre SRI International have partnered to discover and develop drugs to treat various viruses, including the novel coronavirus that causes Covid-19 and influenza.
-
Takeda initiates development of a plasma-derived therapy for COVID-19
expresspharma
March 05, 2020
Anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) being developed to treat infected, high-risk individuals with COVID-19.
-
China approves use of Roche arthritis drug for some Covid-19 patients
expresspharma
March 05, 2020
Tocilizumab, sold by the Swiss pharma giant under the trade name Actemra, can be prescribed to coronavirus patients who show serious lung damage.